Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Poor Quality Products Source quality determines outcomes more than any other single factor
The peptide is currently in a regulatory gray area, neither approved for compounding nor formally restrictedbut as of now, a licensed clinician cannot prescribe it for use in compounded medications
In 2023, the FDA approved a longer-acting IL1 blocking medication called canakinumab (Ilaris) for use in special circumstances
This doubles the potency per unit of volume, which means smaller injection volumes
Research in animal models indicates that AHK-Cu is an effective stimulator of collagen synthesis
US$ 28.46
US$ 21.33
US$ 27.92
US$ 20.48
